Canbi Pharma Tech Limited
1096708-71-2 Tovorafenib

1096708-71-2 Tovorafenib

Product name:Tovorafenib
CAS:1096708-71-2
MF:C17H12Cl2F3N7O2S
MW:506.29
EINECS:
MDL No.:MFCD22571730

Send Inquiry
Description

Properties

Appearance White Solid
Melting point:197-199oC
Boiling point:585.3±50.0 °C 
Density 1.640
pka10.07±0.46 
 

Application:

    Tovorafenib is mainly used to treat recurrent or refractory low-grade gliomas (pLGG) in children with BRAF fusion or rearrangement or BRAF V600 mutations. Tovorafenib is an oral type II RAF kinase inhibitor that can specifically target BRAF gene mutations, especially BRAF V600E and V600D mutations, as well as BRAF fusion mutations.
 

Synonyms:

Tovorafenib

(r)-2-(1-(6-amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide

2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide

6-AMINO-5-CHLORO-N-[(1R)-1-(5-{[5-CHLORO-4-(TRIFLUOROMETHYL)PYRIDIN-2-YL]CARBAMOYL}-1,3-THIAZOL-2-YL)ETHYL]PYRIMIDINE-4-CARBOXAMIDE

2-((1R)-1-((6-amino-5-chloropyrimidine-4-carbonyl)amino)ethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)-1,3-thiazole-5-carboxamide

6-amino-5-chloro-N-((1R)-1-(5-((5-chloro-4-(trifluoromethyl)pyridin-2-yl)carbamoyl)-1,3-thiazol-2-yl)ethyl)pyrimidine-4-carboxamide

6-amino-5-chloro-N-(1R)-1-(5-(((5-hloro-4-(trifluoromethyl)-2pyridinyl)amino)carbonyl)-2-thiazoyl)ethyl)-4-pyrimdinecarboxamide

 

Hot Tags: 1096708-71-2 tovorafenib, China 1096708-71-2 tovorafenib manufacturers, suppliers, api data privacy, L-carnitine, api car rental api integration, Atovaquone, api versioning, api authorization systems

Inquiry
goTop

(0/10)

clearall